Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/28/25 17:23 | 1/24/25 | XOMA | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | S.d | -16,984 | 26.10 | 0 | -651 | -100 | 0 | M | |||||||||||||||
11/13/24 18:55 | 11/13/24 | XOMA | Health | Drug | Pharmaceutical Preparations | Burns Thomas M. | CA | O | SVP,Fina | S.d | -293 | 29.94 | 0 | -10 | -30 | 23 | D | ||||||||||||||
11/13/24 18:55 | 11/13/24 | XOMA | Health | Drug | Pharmaceutical Preparations | Hughes Owen | CA | DO | CEO | S.d | -655 | 29.95 | 0 | -22 | -37 | 37 | D | ||||||||||||||
7/18/22 16:30 | 7/15/22 | XOMA | Health | Drug | Pharmaceutical Preparations | Burns Thomas M. | CA | O | SVP,Fina | S.d | -63 | 31.66 | 0 | -2 | -13 | 14 | D | ||||||||||||||
7/18/22 16:30 | 7/15/22 | XOMA | Health | Drug | Pharmaceutical Preparations | Neal James R | CA | DO | CEO | S.d | -746 | 29.84 | 0 | -25 | -43 | 33 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |